Will Rua Bioscience spark more NZX cannabis entrants?

Will Rua Bioscience spark more NZX cannabis entrants?
Brent Melville
Rua Bioscience was trading at 69 cents from its 50 cent listing price within a few hours of becoming the first NZX public listing of the year.The second medicinal cannabis company after Cannasouth to head to the NZX had raised $20 million in its initial public offering earlier this week.The oversubscribed IPO saw 10 million of the 40 million shares allocated through a priority offer to Tairāwhiti residents and Waiapu Investments shareholders.Lead manager Northington Partners reported about 86 percent of those applicants had received their share...

More Listed Companies

Millennium & Copthorne plans new hotel in Whangārei CBD
Listed Companies

Millennium & Copthorne plans new hotel in Whangārei CBD

The company has a site under contract for $2.24 million.

John Anthony 26 Apr 2024
How ‘shareholder value’ became a Wall Street mantra
Policy

How ‘shareholder value’ became a Wall Street mantra

Michael Jensen inspired the transformation of capitalism. Was he a hero or a villain?

Bloomberg 13 Apr 2024
How many boards should a director sit on?
Listed Companies

Simon Robertson: How many boards should a director sit on?

An attempt to judge the composition trends in NZX boards is challenging.

Simon Robertson 13 Apr 2024
Wellington council picks Precinct for major civic square project
Property

Wellington council picks Precinct for major civic square project

Firm will fund and build the new five-star green building.

Staff reporters 11 Apr 2024